Glycyl-L-Histidyl-L-Lysine Copper Complex
A naturally occurring tripeptide that binds copper and acts as a master regulator of tissue repair. Originally identified in human plasma, GHK-Cu levels decline sharply with age — from ~200 ng/mL at age 20 to ~80 ng/mL by age 60. Now the fastest-growing peptide in search globally at +1,016% year-over-year.
01 — Research Summary
GHK-Cu has accumulated one of the most substantial research portfolios of any cosmetic or longevity peptide. First identified in human plasma by Loren Pickart in 1973, it was originally noted for its ability to stimulate liver tissue repair. Over five decades, research has expanded to reveal a compound with profound systemic effects well beyond skin.
The most striking finding is genomic: gene expression studies suggest GHK-Cu may modulate over 4,000 human genes, with a net shift toward a younger expression pattern. It appears to simultaneously reset genes associated with inflammation, tissue repair, collagen synthesis, and antioxidant defense — a profile no single synthetic drug matches.
In human clinical studies, topical GHK-Cu has demonstrated measurable improvements in skin density, firmness, fine line depth, and wound healing velocity. Hair growth studies show meaningful improvements in follicle size and density in androgenic alopecia subjects.
4,000+ gene modulation. Comprehensive analysis confirmed GHK-Cu's ability to shift human gene expression toward younger phenotype patterns, with upregulation of collagen, antioxidant, and tissue repair genes.
Significant wrinkle reduction. 12-week topical application showed statistically significant reduction in fine lines and improved skin density versus placebo. Results comparable to 0.05% retinol with superior tolerability.
Follicle enlargement and density. Scalp application for 6 months showed statistically significant increases in hair follicle size and density in pattern hair loss subjects, via VEGF upregulation in follicles.
Accelerated wound closure. GHK-Cu applied to surgical wounds demonstrated significantly faster re-epithelialization and reduced scar formation compared to standard-of-care dressings.
CNS protective effects. Animal model data suggests GHK-Cu upregulates NGF expression and modulates superoxide dismutase (SOD) — an antioxidant enzyme whose decline correlates with neurodegeneration.
02 — Mechanism of Action
GHK-Cu operates through several parallel pathways simultaneously. Unlike most peptides that activate a single receptor, GHK-Cu functions as a master reset signal — reversing gene expression patterns associated with aging and damage across multiple biological systems at once.
GHK binds copper (Cu²⁺) with high affinity, delivering it to copper-dependent enzymes including lysyl oxidase (collagen/elastin crosslinking), cytochrome c oxidase (mitochondrial energy), and superoxide dismutase (antioxidant defense).
Stimulates fibroblast production of collagen I, III, IV, fibronectin, dermatan sulfate, and glycosaminoglycans (including hyaluronic acid). Activates decorin, which regulates collagen fibril assembly and tissue structural integrity.
Modulates transcription factor activity to shift gene expression toward a youthful phenotype — upregulating tissue repair, antioxidant, and anti-inflammatory genes while downregulating pro-inflammatory and cancer-associated gene clusters.
Upregulates VEGF and FGF, stimulating new blood vessel formation. Improves nutrient and oxygen delivery to healing tissue and drives hair follicle revival by restoring scalp microcirculation.
Inhibits TNF-α and TGF-β1. TGF-β1 inhibition specifically reduces fibrosis and scar formation, promoting clean tissue regeneration rather than scarring — a key advantage over most healing compounds.
GHK-Cu's simultaneous activity across collagen synthesis, angiogenesis, gene reprogramming, and inflammation control is why it produces results across apparently unrelated conditions. Skin aging, wound healing, hair loss, and neuroprotection all share the same underlying biological drivers that GHK-Cu addresses at the root level.
03 — Dosing Protocols
GHK-Cu is unique among health peptides in having both well-established topical and injectable protocols. The topical route is far lower risk, requires no reconstitution, and is appropriate for general skincare and hair applications. Injectable protocols are used for systemic or intensive longevity applications and require sterile technique.
| Protocol | Dose | Frequency | Duration | Notes |
|---|---|---|---|---|
| Topical — skin aging | 1–3% | 1–2× daily | 12+ weeks | Apply after cleansing, before moisturiser. AM/PM use acceptable. |
| Topical — hair loss | 2–5% | 1× daily | 16–24 weeks | Apply to scalp and massage in. Leave-on formulation preferred. |
| Topical — wound healing | 2% | 2× daily | Until healed | Apply to clean wound. Studied in post-surgical applications. |
| Injectable — subcutaneous | 1–2 mg | 2–3× / week | 4–8 weeks | Reconstitute with bacteriostatic water. Rotate injection sites. |
| Injectable — longevity | 2 mg | Daily or EOD | 8–12 weeks | Systemic anti-aging protocol. Often stacked with Epithalon. |
Reconstitution: Add 1–2 mL bacteriostatic water per 5 mg vial. Swirl gently — do not shake. Store refrigerated at 2–8°C. Use within 28 days. Discard if cloudy or particulate matter is present.
Cycling: Injectable protocols typically run 8–12 week cycles with 4–6 week breaks. Topical use can be continuous — no known tolerance development reported in literature.
All dosing information is drawn from published research and community protocols for educational purposes only. GHK-Cu is not FDA-approved for human therapeutic use. Consult a licensed healthcare professional before initiating any peptide protocol.
04 — Community Experiences
The following links surface real discussions from public research and wellness communities. These are anecdotal reports — not clinical evidence — and results vary significantly between individuals. We curate these as a transparency resource so you can read unfiltered user experiences alongside the science.
These are user-reported experiences from public forums. They are not endorsed by Whats That Peptide and should not be interpreted as clinical evidence of efficacy or safety. Individual results vary. Always consult a healthcare professional before starting any peptide protocol.
"I was skeptical but the before/after on my forehead lines is genuinely hard to argue with. Texture improvement was first around week 6, then firmness around week 10. Nothing dramatic but consistent and real..."
"Added GHK-Cu serum to my existing finasteride + minoxidil stack. Hard to isolate the variable but density in my temples has improved noticeably. Hair feels thicker at the shaft too. Will continue..."
"Running it injectable alongside Epithalon cycles. Bloodwork markers have shifted in positive directions, skin is noticeably different to what it was 3 years ago, energy is stable. This is the compound I'm most confident keeping long term..."
"Ran topical for 4 months, switched to subcutaneous for 3 months. The injectable version had more noticeable systemic effects — sleep quality and mood both improved in ways topical didn't. Still use topical for skin specifically..."